Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Nature Index Cancer is now available

 
 
 
A cornerstone of scientific activity in many countries, cancer research is producing game-changing work for universal gain. But inequalities in the field risk blunting its potential to save lives. 
 
This supplement explores:
 
 
 
  • How Ukraine is fighting for its place in clinical trials as war drags on.
  • AI drug discovery, therapeutic vaccines and other new ways to outwit cancer’s evasion tactics. 
  • Why it is crucial to correct skewed research spend and shore up basic intervention.
  • The global leaders in cancer research: by the numbers. 
 
 
Access now
 
Image credit: Eva Vázquez
 
 
© Nature Portfolio
 
 
 
This email has been sent to [email protected].

As a registered user of Nature Portfolio websites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these marketing emails from Nature Portfolio please click here to unsubscribe.

If you wish to discontinue all email services from Nature Portfolio please click here to unsubscribe. 
 
Springer Nature Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Portfolio | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
 
 
© 2023  Nature Portfolio. Part of Springer Nature. All rights reserved.  
31914
 
 


This post first appeared on Clinical Trials News, please read the originial post: here

Share the post

Nature Index Cancer is now available

×

Subscribe to Clinical Trials News

Get updates delivered right to your inbox!

Thank you for your subscription

×